Orison O Woolcott1, Richard N Bergman1. 1. Sports Spectacular Diabetes and Obesity Wellness and Research Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Abstract
Woolcott, Orison O., and Richard N. Bergman. Mortality attributed to COVID-19 in high-altitude populations. High Alt Med Biol. 21:409-416, 2020. Background: Since partial oxygen pressure decreases as altitude increases, environmental hypoxia could worsen Coronavirus Disease 2019 (COVID-19) patient's hypoxemia. We compared COVID-19 mortality at different altitudes. Methods: Retrospective analysis of population-level data on COVID-19 deaths was conducted in the United States (1,016 counties) and Mexico (567 municipalities). Mixed-model Poisson regression analysis of the association between altitude and COVID-19 mortality was conducted using individual-level data from 40,168 Mexican subjects with COVID-19, adjusting for multiple covariates. Results: Between January 20 and April 13, 2020, mortality rates were higher in U.S. counties located at ≥2,000 m elevation versus those located <1,500 m (12.3 vs. 3.2 per 100,000; p < 0.001). In Mexico, between March 13 and May 13, 2020, mortality rates were higher in municipalities located at ≥2,000 m versus those located <1,500 m (5.3 vs. 3.9 per 100,000; p < 0.001). Among Mexican subjects younger than 65 years, the risk of death was 36% higher in those living at ≥2,000 m versus those living at <1,500 m (adjusted incidence rate ratio [IRR]: 1.36; confidence interval [95% CI], 1.05-1.78; p = 0.022). Among Mexican men, the risk of death was 31% higher at ≥2,000 m versus that at <1,500 m (adjusted IRR: 1.31; 95% CI, 1.03-1.66; p = 0.025). No association between altitude and COVID-19 mortality was found among Mexican women or among Mexican subjects 65 years of age and older. Conclusions: Altitude is associated with COVID-19 mortality in men younger than 65 years.
Woolcott, Orison O., and Richard N. Bergman. Mortality attributed to COVID-19 in high-altitude populations. High Alt Med Biol. 21:409-416, 2020. Background: Since partial oxygen pressure decreases as altitude increases, environmental hypoxia could worsen Coronavirus Disease 2019 (COVID-19) patient's hypoxemia. We compared COVID-19mortality at different altitudes. Methods: Retrospective analysis of population-level data on COVID-19deaths was conducted in the United States (1,016 counties) and Mexico (567 municipalities). Mixed-model Poisson regression analysis of the association between altitude and COVID-19mortality was conducted using individual-level data from 40,168 Mexican subjects with COVID-19, adjusting for multiple covariates. Results: Between January 20 and April 13, 2020, mortality rates were higher in U.S. counties located at ≥2,000 m elevation versus those located <1,500 m (12.3 vs. 3.2 per 100,000; p < 0.001). In Mexico, between March 13 and May 13, 2020, mortality rates were higher in municipalities located at ≥2,000 m versus those located <1,500 m (5.3 vs. 3.9 per 100,000; p < 0.001). Among Mexican subjects younger than 65 years, the risk of death was 36% higher in those living at ≥2,000 m versus those living at <1,500 m (adjusted incidence rate ratio [IRR]: 1.36; confidence interval [95% CI], 1.05-1.78; p = 0.022). Among Mexican men, the risk of death was 31% higher at ≥2,000 m versus that at <1,500 m (adjusted IRR: 1.31; 95% CI, 1.03-1.66; p = 0.025). No association between altitude and COVID-19mortality was found among Mexican women or among Mexican subjects 65 years of age and older. Conclusions: Altitude is associated with COVID-19mortality in men younger than 65 years.
Authors: Charles Huamaní; Lucio Velásquez; Sonia Montes; Ana Mayanga-Herrera; Antonio Bernabé-Ortiz Journal: PeerJ Date: 2021-09-20 Impact factor: 2.984
Authors: Katherine Simbaña-Rivera; Pablo R Morocho Jaramillo; Javier V Velastegui Silva; Lenin Gómez-Barreno; Ana B Ventimilla Campoverde; Juan F Novillo Cevallos; Washington E Almache Guanoquiza; Silvio L Cedeño Guevara; Luis G Imba Castro; Nelson A Moran Puerta; Alex W Guayta Valladares; Alex Lister; Esteban Ortiz-Prado Journal: PLoS One Date: 2022-03-31 Impact factor: 3.240
Authors: Manuel Jibaja; Estefania Roldan-Vasquez; Jordi Rello; Hua Shen; Nelson Maldonado; Michelle Grunauer; Ana María Díaz; Fernanda García; Vanessa Ramírez; Hernán Sánchez; José Luis Barberán; Juan Pablo Paredes; Mónica Cevallos; Francisco Montenegro; Soraya Puertas; Killen Briones; Marlon Martínez; Jorge Vélez-Páez; Mario Montalvo-Villagómez; Luis Herrera; Santiago Garrido; Ivan Sisa Journal: J Intensive Care Med Date: 2022-05-09 Impact factor: 2.889
Authors: Jesús Castilla; Ujué Fresán; Camino Trobajo-Sanmartín; Marcela Guevara Journal: Int J Environ Res Public Health Date: 2021-03-04 Impact factor: 3.390
Authors: Javier Leonardo Galindo; Juan Ricardo Lutz; María Alejandra Izquierdo; Katherine Parra; Lina María Prieto; Jorge Alberto Carrillo Journal: Can Respir J Date: 2021-06-08 Impact factor: 2.409
Authors: Eder Cano-Pérez; Jaison Torres-Pacheco; María Carolina Fragozo-Ramos; Génesis García-Díaz; Eduardo Montalvo-Varela; Juan Carlos Pozo-Palacios Journal: Am J Trop Med Hyg Date: 2020-10-26 Impact factor: 3.707